Leonard S. Schleifer, CEO & President at REGENERON PHARMACEUTICALS INC (REGN), sold 5,000 shares at $276.47 ($1.4M) on 2013-09-09, disclosed to the SEC on 2013-09-11.
Scheduled sale ($1.4M) by CEO & President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $275.04 | 3,600 | $990K | 71.9% |
| 2 | $276.47 | 1,200 | $332K | 24.1% |
| 3 | $277.12 | 200 | $55K | 4.0% |
| Total | $275.47 avg | 5,000 | $1.4M | 100% |
| Filing → |
| REGN | SELL | 2024-05-17 | $44.7M | — | Filing → |
| REGN | SELL | 2024-05-15 | $70.1M | — | Filing → |
| REGN | SELL | 2022-04-07 | $10.1M | — | Filing → |